Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
PAX5 deficiency causing neurodevelopmental abnormalities including autism spectrum disorder in addition to hypogammaglobulinemia due to early B cell developmental block and impaired immune responses.
No clinical trials have been registered for PAX5-related B lymphopenia and autism spectrum disorder.
2 publications have been identified in PubMed for PAX5-related B lymphopenia and autism spectrum disorder. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Jans D (2026). [PMID: 41972176](https://pubmed.ncbi.nlm.nih.gov/41972176/). *Front Immunol*. [Review / Meta-Analysis]
Moreno-Corona N (2026). [PMID: 42099922](https://pubmed.ncbi.nlm.nih.gov/42099922/). *J Hum Immun*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:35 PM UTC
Common questions about PAX5-related B lymphopenia and autism spectrum disorder